Your browser doesn't support javascript.
loading
Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
Floege, Jürgen; Barbour, Sean J; Cattran, Daniel C; Hogan, Jonathan J; Nachman, Patrick H; Tang, Sydney C W; Wetzels, Jack F M; Cheung, Michael; Wheeler, David C; Winkelmayer, Wolfgang C; Rovin, Brad H.
Afiliação
  • Floege J; Division of Nephrology, Rheinisch-Westfälische Technische Hochschule University of Aachen, Aachen, Germany. Electronic address: jfloege@ukaachen.de.
  • Barbour SJ; British Columbia Provincial Renal Agency, Vancouver, British Columbia, Canada; Division of Nephrology, University of British Columbia, Vancouver, British Columbia, Canada; Centre for Health Evaluation and Outcomes Research, St. Paul's Hospital, Vancouver, British Columbia, Canada.
  • Cattran DC; Toronto General Research Institute, University Health Network, Toronto, Ontario, Canada.
  • Hogan JJ; Division of Nephrology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Nachman PH; Division of Renal Diseases and Hypertension, University of Minnesota, Minneapolis, Minnesota, USA.
  • Tang SCW; Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, China.
  • Wetzels JFM; Department of Nephrology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Cheung M; KDIGO, Brussels, Belgium.
  • Wheeler DC; University College London, London, UK.
  • Winkelmayer WC; Selzman Institute for Kidney Health, Section of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
  • Rovin BH; Division of Nephrology, The Ohio State University, Wexner Medical Center, Columbus, Ohio, USA. Electronic address: rovin.1@osu.edu.
Kidney Int ; 95(2): 268-280, 2019 02.
Article em En | MEDLINE | ID: mdl-30665568
The Kidney Disease: Improving Global Outcomes (KDIGO) initiative organized a Controversies Conference on glomerular diseases in November 2017. The conference focused on the 2012 KDIGO guideline with the aim of identifying new insights into nomenclature, pathogenesis, diagnostic work-up, and, in particular, therapy of glomerular diseases since the guideline's publication. It was the consensus of the group that most guideline recommendations, in particular those dealing with therapy, will need to be revisited by the guideline-updating Work Group. This report covers general management of glomerular disease, IgA nephropathy, and membranous nephropathy.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glomerulonefrite Membranosa / Guias de Prática Clínica como Assunto / Insuficiência Renal Crônica / Glomerulonefrite por IGA Tipo de estudo: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Kidney Int Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glomerulonefrite Membranosa / Guias de Prática Clínica como Assunto / Insuficiência Renal Crônica / Glomerulonefrite por IGA Tipo de estudo: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Kidney Int Ano de publicação: 2019 Tipo de documento: Article